Medtronic, Inc. (MDT)
-NYSE | Prev Close: | 52.05 |
|---|
| Open: | N/A |
|---|
| Bid: | 50.35 x 100 |
|---|
| Ask: | 53.41 x 300 |
|---|
| 1y Target Est: | 55.50 |
|---|
| Beta: | 1.01 |
|---|
| Next Earnings Date: | 20-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 36.91 - 53.83 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 4,733,060 |
|---|
| Market Cap: | 52.88B |
|---|
| P/E (ttm): | 15.45 |
|---|
| EPS (ttm): | 3.37 |
|---|
| Div & Yield: | 1.04 (2.00%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Final Glance: Medical Devices companiesAP(Wed, Jun 19)
- NuVasive rises as analyst looks to profit marginsAP(Wed, Jun 19)
- Is a Type 1 Diabetes Cure Right Around the Corner?at Motley Fool(Wed, Jun 19)
- Midday Glance: Medical Devices companiesAP(Wed, Jun 19)
- A Discounted Medical Equipment Playat Motley Fool(Wed, Jun 19)
- No More Secrets: Medtronic Shows How Open Science Might Work In The Real Worldat Forbes(Wed, Jun 19)
- Early Glance: Medical Devices companiesAP(Wed, Jun 19)
- MDT Expands Spine-Line in EuropeZacks(Wed, Jun 19)
- Analysts: SodaStream Sales Are Picking Up and 3 More Research Notes to Look Overat Wall St. Cheat Sheet(Tue, Jun 18)
- Medtronic’s Infuse No Better Than Bone Graft With Riskat Bloomberg(Tue, Jun 18)
- BSX Commences U.S. INTREPID TrialZacks(Tue, Jun 18)
- Movers roundup: Medtronic, Newfield ExplorationAP(Tue, Jun 18)
- United Continental Puts Down Big Boeing Order and 3 More Hot Stocksat Wall St. Cheat Sheet(Tue, Jun 18)
- Dividend Champions: 8 Increases Expected By Labor Dayat Seeking Alpha(Tue, Jun 18)
- Medtronic slips after Infuse reviews detailedAP(Tue, Jun 18)
Key Statistics
| Forward P/E (1 yr): | 12.60 |
|---|
| P/S (ttm): | 3.19 |
|---|
| Ex-Dividend Date: | 03-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Apr-14)
: | 3.84 |
|---|
| Quarterly EPS Est
(Jul-13)
: | 0.88 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 2.00 |
|---|
Business Summary
Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It provides products to diagnose, treat, and manage heart rhythm disorders and heart failure, including implantable cardiac pacemakers, implantable cardioverter defib...
View More